Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week placebo-controlled phase 2 study of L-000124467 in rheumatoid arthritis
2004-000074-31Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mk-0812 in rheumatoid arthritis (RA) (3 arms), sponsored by Merck & Co. Primary endpoint: Swollen joint count. Started May 2004; status: completed.
02
Drugs
mk-0812
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-000074-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000074-31.